Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G4A | P47712 | 2/20 | 0.40 |
| ▸ | SAT1 | P21673 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.36 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.36 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.36 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.35 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.34 |
| ▸ | SGPL1 | O95470 | 4/20 | 0.34 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19973408 | 0.76 | ALDH1A1 (0.63) | SAT1ALDH1A1LPAR3LPAR1LPAR2 | |
| SCHEMBL16815002 | 0.75 | LPAR3 (0.56) | SAT1ALDH1A1LPAR3LPAR1LPAR2 | |
| SCHEMBL16815019 | 0.75 | LPAR3 (0.56) | SAT1ALDH1A1LPAR3LPAR1LPAR2 | |
| SCHEMBL16815020 | 0.75 | LPAR3 (0.56) | SAT1ALDH1A1LPAR3LPAR1LPAR2 | |
| SCHEMBL25787131 | 0.74 | SAT1 (0.44) | SAT1LPAR3LPAR1LPAR2 | |
| SCHEMBL17754043 | 0.74 | LPAR3 (0.57) | ALDH1A1LPAR3LPAR1LPAR2PAOX | |
| SCHEMBL11952610 | 0.73 | BTN3A1 (0.43) | SAT1ALDH1A1LPAR3LPAR1LPAR2 | |
| SCHEMBL12914742 | 0.73 | SAT1 (0.57) | SAT1ALDH1A1LPAR3LPAR1LPAR2 | |
| SCHEMBL19628772 | 0.72 | FFAR1 (0.55) | FFAR4FFAR1 | |
| SCHEMBL11452026 | 0.72 | PAOX (0.45) | ALDH1A1PAOXFFAR4FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080182980-A1 | Reactive Functional Groups | THIRD WAVE TECHNOLOGIES, INC. (US) | 2008-07-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080182980-A1 | Reactive Functional Groups | POLRMT, RNGTT, APEX1 | PLA2G4A 631/4885SAT1 2087/4885ALDH1A1 2049/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.